Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Shibo Jindu Pharmaceutical is a comprehensive pharmaceutical enterprise located in Zibo, Shandong Province, China. Founded in 2004, the company focuses on the research, production, and sales of chemical drugs and traditional Chinese medicine preparations. Its product line includes well-known brands for treating the common cold, such as Compound Paracetamol and Amantadine Hydrochloride capsules, as well as antibiotics and cardiovascular treatments. The company maintains large-scale manufacturing facilities that are GMP-certified, ensuring high-quality production of tablets, capsules, and granules for the Chinese healthcare market. Shibo Jindu is recognized as a high-tech enterprise in its region and emphasizes the integration of traditional medicine with modern pharmaceutical technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Shibo Jindu Pharmaceutical.